Peptide record

TPDB92406

PFV Antibacterial Antiviral Blood-Brain Barrier Cell-penetrating Peptides modified_plain modified
6 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92406
PFV
Antibacterial Antiviral Blood-Brain Barrier Cell-penetrating Peptides
Anti-infective peptides Delivery and barrier-penetrating peptides
Peptipedia dbAMP 3.0 DRAVP 2.0 B3Pred BBPpredict CellPPD CellPPD-MOD CPPsite3.0 MLCPP 2.0 PerseuCPP
modified_plain
Yes
A 6-aa modified multi-activity (Antibacterial, Antiviral, Blood-Brain Barrier, and other sources) peptide sequence curated from Peptipedia, dbAMP 3.0, DRAVP 2.0, and other sources, with an available 3D structural model.
C-terminal: Amidation Chemical: Transferrin (Tf) liposomes
Sequence
PFVYLI-NH2
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
6 reviewed residue count
Amidation Activity
Transferrin (Tf) liposomes Activity
L Activity
Cationic Activity
Linear Activity
Free Activity
N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Cell-penetrating Peptides

Target

U87, bEnd.3 And Glial Cells , In Vitro 3D Brain Tumor Model

Source & Reference

CPPsite3.0
CPPsite3

Other

Source Activity Label Source Definition
Cell-penetrating Peptides
CPPsite3.0 experimentally validated cell-penetrating peptide annotation.
Natural residues Linear L Cationic
Synthetic
Doxorubicin (Dox) and Erlotinib (Erlo)
Cytoplasm and nucleus
The Dox uptake from the Tf-PFV liposomes showed approximately 66%, 66%, and 65% and Erlo was found to be approximately 69%, 68%, and 64% in U87, bEnd.3, and Primary glial cells, respectively. Tf-PFV liposomes showed significantly higher (p < 0.05) cellular uptake compared to single ligand or plain liposomes.
Clathrin-mediated endocytosis as well as clathrin-coated vesicles.
In vitro
CCSSSSCSSCCHHHHHTTTCC
Additional Detail Fields 1 fields
CCSSSSCSSCCHHHHHTTTCC